These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7682515)

  • 1. Detection of antibodies to hepatitis C virus in dialysis patients.
    Rivanera D; Lilli D; Lorino G; Pirozzi V; Cannulla V; Dicuonzo G; Mancini C
    Eur J Epidemiol; 1993 Jan; 9(1):55-8. PubMed ID: 7682515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to hepatitis C virus by second generation test in hemodialyzed patients.
    Chauveau P; Courouce AM; Lemarec N; Naret C; Poignet JL; Girault A; Ramdame M; Delons S
    Kidney Int Suppl; 1993 Jun; 41():S149-52. PubMed ID: 7686591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus infection among chronic dialysis patients in the south of France: a collaborative study.
    Dussol B; Berthezène P; Brunet P; Roubicek C; Berland Y
    Am J Kidney Dis; 1995 Mar; 25(3):399-404. PubMed ID: 7532916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of anti-hepatitis C virus detection with ELISA assay and RIBA 4 in dialysis patients: our experience.
    Innocenti M; Mazzoni A; Moretti A; Palla P
    Nephron; 1992; 61(3):315. PubMed ID: 1380132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to hepatitis C virus (anti-HCV): prevalence in the same geographical area in dialysis patients, staff members, and blood donors.
    Malaguti M; Capece R; Marciano M; Arena G; Luciani MP; Striano M; Biagini M
    Nephron; 1992; 61(3):346. PubMed ID: 1323786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of hepatitis C virus antibodies in hemodialysis patients and dialysis staff.
    Fujiyama S; Kawano S; Sato S; Tanaka M; Goto M; Taura Y; Sato T; Kawahara T; Mizuno K
    Hepatogastroenterology; 1992 Apr; 39(2):161-5. PubMed ID: 1378811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroepidemiology of hepatitis C virus infection in Japan and HCV infection in haemodialysis patients.
    Yamaguchi K; Kiyokawa H; Machida J; Obayashi A; Nojiri N; Ueda S; Takatsuki K
    FEMS Microbiol Rev; 1994 Jul; 14(3):253-8. PubMed ID: 7522023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis--a multicenter study.
    Gladziwa U; Schlipköter U; Lorbeer B; Cholmakow K; Roggendorf M; Sieberth HG
    Clin Nephrol; 1993 Jul; 40(1):46-52. PubMed ID: 7689431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C antibodies in dialysis patients and patients with leukaemia.
    Kolho E; Oksanen K; Honkanen E; Naukkarinen R; Krusius T
    J Med Virol; 1993 Aug; 40(4):318-21. PubMed ID: 8228923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members].
    Miyasaka M
    Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of an optional HCV screening program for blood transfusion recipients in Ireland.
    Davoren A; Dillon AD; Power JP; Donnellan J; Quinn JM; Willis JW; Lawlor EM; O'Riordan JM
    Transfusion; 2002 Nov; 42(11):1501-6. PubMed ID: 12421225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of hepatitis C antibodies (HCV) in a dialysis population at one center.
    Selgas R; Martinez-Zapico R; Bajo MA; Romero JR; Munoz J; Rinon C; Miranda B; Miguel JL
    Perit Dial Int; 1992; 12(1):28-30. PubMed ID: 1311962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-hepatitis C virus screening will reduce the incidence of post-transfusion hepatitis C also in low-risk areas.
    Mathiesen UL; Ekermo B; Foberg U; Franzén L; Frydén A; Norlin R; Pettersson LG; Sterling H; Widell A; Bodemar G
    Scand J Gastroenterol; 1992 Jun; 27(6):443-8. PubMed ID: 1321487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Environmental transmission of hepatitis B and hepatitis C viruses within the hemodialysis unit.
    Cendoroglo Neto M; Manzano SI; Canziani ME; Silva AE; Cirenza LF; Sesso Rde C; Ajzen H; Draibe SA
    Artif Organs; 1995 Mar; 19(3):251-5. PubMed ID: 7539998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of antibodies to hepatitis C virus in three haemodialysis centres in south-western Poland.
    Hruby Z; Sliwiński J; Molin I; Zalewska M; Knysz B; Czyz W; Steciwko A; Bogucki J; Gładysz A
    Nephrol Dial Transplant; 1993; 8(8):740-3. PubMed ID: 7692355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hepatitis C virus antibodies in hemodialysis patients in the area of Milan.
    Gubertini G; Scorza D; Beccari M; Buccianti G; Costantino A; Spotti D; Graziani G
    Nephron; 1992; 61(3):271-2. PubMed ID: 1323769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus antibodies in dialysis pediatric patients.
    Di Loreto M; Ferrante M; Panaro A; Sorino P; Collela V; Caringella DA
    Nephron; 1992; 61(3):365-6. PubMed ID: 1323793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies against hepatitis C virus (anti-HCV) in haemodialysis patients: association with hepatitis B serological markers.
    Elisaf M; Tsianos E; Mavridis A; Dardamanis M; Pappas M; Siamopoulos KC
    Nephrol Dial Transplant; 1991; 6(7):476-9. PubMed ID: 1717891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of anti-HCV antibodies in hemodialysis patients.
    Fujiyama S; Kawano S; Sato S; Sato T; Shimada H; Matsushita K; Hara M; Ito J
    Gastroenterol Jpn; 1991 Jul; 26 Suppl 3():206-8. PubMed ID: 1909269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of anti-hepatitis C virus antibodies among teenagers in the Venetian area: a seroepidemiological study.
    Gessoni G; Manoni F
    Eur J Med; 1993 Feb; 2(2):79-82. PubMed ID: 7504974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.